Keywords: Alexza, Adasuve, PDUFA date, USA, FDA, Public Citizen, Antipsychotic

PDUFA goal date for Alexza’s Adasuve extended, as Public Citizen says drug should not be approved

Article | 25 January 2012

Print This

US drug firm Alexza Pharmaceuticals (Nasdaq: ALXA) says that the US Food and Drug Administration will require additional time to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in